Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (review of HST12): A Highly Specialised Technology Evaluation

Ana Isabel Duarte; Mark Stephen Corbett; Anqian Zhou; Chinyereugo Umemneku-Chikere; Helen Fulbright; Natalia Kunst; Mark Crawford Simmonds

Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (review of HST12): A Highly Specialised Technology Evaluation

Research output: Book/Report › Commissioned report

Original language	English
Publisher	National Institute for Health and Care Excellence
Commissioning body	National Institute for Health and Care Excellence
Publication status	Published - 15 May 2025

Access to Document

http://Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (review of HST12)

Cite this

Duarte, A. I., Corbett, M. S., Zhou, A., Umemneku-Chikere, C., Fulbright, H., Kunst, N., & Simmonds, M. C. (2025). Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (review of HST12): A Highly Specialised Technology Evaluation. National Institute for Health and Care Excellence. http://Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (review of HST12)

@book{fd535ec78c2f4265b64e0619ab24aab8,

title = "Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (review of HST12): A Highly Specialised Technology Evaluation",

author = "Duarte, \{Ana Isabel\} and Corbett, \{Mark Stephen\} and Anqian Zhou and Chinyereugo Umemneku-Chikere and Helen Fulbright and Natalia Kunst and Simmonds, \{Mark Crawford\}",

year = "2025",

month = may,

day = "15",

language = "English",

publisher = "National Institute for Health and Care Excellence",

}

Duarte, AI , Corbett, MS , Zhou, A , Umemneku-Chikere, C , Fulbright, H , Kunst, N & Simmonds, MC 2025, Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (review of HST12): A Highly Specialised Technology Evaluation. National Institute for Health and Care Excellence. <http://Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (review of HST12)>

TY - BOOK

T1 - Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (review of HST12)

T2 - A Highly Specialised Technology Evaluation

AU - Duarte, Ana Isabel

AU - Corbett, Mark Stephen

AU - Zhou, Anqian

AU - Umemneku-Chikere, Chinyereugo

AU - Fulbright, Helen

AU - Kunst, Natalia

AU - Simmonds, Mark Crawford

PY - 2025/5/15

Y1 - 2025/5/15

M3 - Commissioned report

BT - Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (review of HST12)

PB - National Institute for Health and Care Excellence

ER -